Robots in the OR: Mazor Robotics unveils its latest surgical robot | Regulatory Roundup

June 6, 2011 by MassDevice staff

Mazor's next-gen robot expands potential spinal applications for machine-guided surgery.

M and A Roundup

Mazor Robotics Ltd. (TASE:MZOR) unveiled its new Renaissance device, the next generation of its spinal robotic surgical guidance systems technology, which extend potential applications to more complex spine surgeries.

The new system is built on the core of the previous generation SpineAssist technology, which has been successfully used in more than 2,000 surgeries worldwide, accurately placing more than 12,000 implants, according to company officials.

The Israel-based company also touted positive findings from a 14-site international multicenter study published in the journal Spine, which showed that Mazor robotics technology "offers enhanced performance in spinal surgery when compared to freehand surgeries, by increasing placement accuracy and reducing neurologic risks," according to the release.

The Renaissance device features a new design and human interface, and well as updated hardware and software. The upgrades are designed to increase safety as well as extend potential surgical applications for the robot. The last generation could accomplish spinal fusions and scoliosis corrections, but the new generation can assist in osteotomies and implant placements.

Renaissance also serves as a platform that will support future clinical applications, such as robotic-guided cranial surgeries, according to the release.

The Renaissance systems already have U.S. regulatory clearance as well as CE Mark approval in the European Union. The company closed a $6.3 million PIPE funding round in February.

Comments